JSPRW
Jasper Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
−38.04%Price chart
Jul 20Jul 30Aug 10Aug 14Aug 20Aug 25Aug 28Sep 2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
Market Cap
$94506.00
MomentumView details →
1D Return
−38.04%
YTD Return
−77.06%
RSI (14)
39.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
Market Cap
$94506.00
RSI (14)
39.3
MomentumView details →
1D Return
−38.04%
YTD Return
−77.06%
Similar companies
Latest newsMore news →
Jasper Therapeutics reported a net loss of $2.76 million for Q2 2026, with diluted loss per share of $0.10, and cash and cash equivalents of $7.3 million as of June 30, 2026.22d agoJasper Therapeutics raised $132 million in a private stock offering.50d agoJasper Therapeutics acquired Kira Pharmaceuticals via a reverse triangular merger, with consideration of Jasper common and convertible preferred stock.50d ago